bibliographic entry 11398862 [be/11398862]
https://w3id.org/oc/corpus/be/11398862

is a
content
  • Oelze M, Kröller‐Schön S, Welschof P et al. The sodium‐glucose co‐transporter 2 inhibitor empagliflozin improves diabetes‐induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity. PLoS One 2014; 9: e112394. PMID: 25402275
references